AR033296A1 - Compuestos triciclicos de pirimidina, proceso para su obtencion, uso de los mismos para la preparacion de una composicion farmaceutica y dicha composicion farmaceutica - Google Patents
Compuestos triciclicos de pirimidina, proceso para su obtencion, uso de los mismos para la preparacion de una composicion farmaceutica y dicha composicion farmaceuticaInfo
- Publication number
- AR033296A1 AR033296A1 ARP020101598A ARP020101598A AR033296A1 AR 033296 A1 AR033296 A1 AR 033296A1 AR P020101598 A ARP020101598 A AR P020101598A AR P020101598 A ARP020101598 A AR P020101598A AR 033296 A1 AR033296 A1 AR 033296A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkynyl
- alkenyl
- haloalkoxy
- haloalkyl
- cyano
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 4
- 150000001875 compounds Chemical class 0.000 title 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 abstract 6
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 abstract 6
- 125000004737 (C1-C6) haloalkoxy group Chemical group 0.000 abstract 4
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 abstract 4
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 4
- 229910052736 halogen Inorganic materials 0.000 abstract 4
- 150000002367 halogens Chemical class 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 4
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 102000012289 Corticotropin-Releasing Hormone Human genes 0.000 abstract 2
- 108010022152 Corticotropin-Releasing Hormone Proteins 0.000 abstract 2
- 239000000055 Corticotropin-Releasing Hormone Substances 0.000 abstract 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 2
- 208000002551 irritable bowel syndrome Diseases 0.000 abstract 2
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 150000003230 pyrimidines Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/16—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Compuestos tricíclicos de pirimidina de formula (1) que incluyen estereo-isomeros, profármacos y sales o solvatos farmacéuticamente aceptables de los mismos, en la cual: R es arilo o heteroarilo, pudiendo estar sustituido cada uno de los grupos R anteriores con 1 a 4 sustituyentes seleccionados independientemente del grupo constituido por: halogeno, alquilo C1-6, alcoxi C1-6, haloalquilo C1-6, alquenilo C2-6, alquinilo C2-6, haloalcoxi C1-6, mono o dialquil-amino C1-6, nitro, ciano y un grupo R4; R1 es hidrogeno, alquilo C1-6, alquenilo C2-6, alquinilo C2-6, haloalquilo C1-6, haloalcoxi C1-6, NH2, halogeno o ciano; R2 es hidrogeno o C(H)n(R5)q(CH2)pZR6; R3 es hidrogeno, alquenilo C2-6, alquinilo C2-6 o [CH(R5)(CH2)p]mZR6; R4 es cicloalquilo C3-7, que puede contener uno o más enlaces dobles; arilo; o un heterociclo de 5-6 miembros; donde cada uno de los grupos R4 anteriores puede estar sustituido con uno o más grupos seleccionados de; halogeno, alquilo C1-6, alcoxi C1-6, haloalquilo C1-6, alquenilo C2-6, alquinilo C2-6, haloalcoxi C1-6, mono- o dialquilamino C1-6, nitro y ciano; R5 es hidrogeno, alquenilo C2-6, alquinilo C2-6 o (CH2)pZR6; R6 es alquilo C1-6, que puede estar sustituido con uno o más grupos seleccionados de halogeno, haloalquilo C1-6, alquenilo C2-6, alquinilo C2-6, haloalcoxi C1-6, alcoxi C1-6, mono- o dialquilamino C1-6, nitro, ciano. Y un grupo R4; Y y X son independientemente carbono o nitrogeno; m y n son independientemente 0 o 1; p es 0 o un numero entero de 1 a 4; q es 1 o 2; Z es un enlace, O, NH o S. Procesos para su obtencion, composiciones farmacéuticas que los contienen y a su uso para preparar dichas composiciones farmacéuticas de utilidad en el tratamiento de condiciones mediadas por el factor liberador de corticotropina (CRF), como depresion, ansiedad, IBS (enfermedad de intestino irritable) e IBD (enfermedad inflamatoria del intestino).
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0110566A GB0110566D0 (en) | 2001-04-30 | 2001-04-30 | Chemical compounds |
| GB0110579A GB0110579D0 (en) | 2001-04-30 | 2001-04-30 | Chemical compounds |
| GB0117423A GB0117423D0 (en) | 2001-07-17 | 2001-07-17 | Chemical compounds |
| GB0203203A GB0203203D0 (en) | 2002-02-11 | 2002-02-11 | Chemical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR033296A1 true AR033296A1 (es) | 2003-12-10 |
Family
ID=27447943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP020101598A AR033296A1 (es) | 2001-04-30 | 2002-04-30 | Compuestos triciclicos de pirimidina, proceso para su obtencion, uso de los mismos para la preparacion de una composicion farmaceutica y dicha composicion farmaceutica |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US7329667B2 (es) |
| EP (1) | EP1383498B1 (es) |
| JP (1) | JP2004528342A (es) |
| KR (1) | KR20040015205A (es) |
| CN (1) | CN1512883A (es) |
| AR (1) | AR033296A1 (es) |
| AT (1) | ATE320254T1 (es) |
| AU (1) | AU2002249474B2 (es) |
| BR (1) | BR0209035A (es) |
| CA (1) | CA2446497A1 (es) |
| CZ (1) | CZ20032945A3 (es) |
| DE (1) | DE60209885T2 (es) |
| ES (1) | ES2255610T3 (es) |
| HU (1) | HUP0304035A2 (es) |
| IL (1) | IL158063A0 (es) |
| MX (1) | MXPA03009930A (es) |
| NO (1) | NO20034837L (es) |
| NZ (1) | NZ528364A (es) |
| PL (1) | PL366854A1 (es) |
| TW (1) | TWI236908B (es) |
| WO (1) | WO2002087573A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0308208D0 (en) | 2003-04-09 | 2003-05-14 | Glaxo Group Ltd | Chemical compounds |
| PL2440558T3 (pl) | 2009-06-08 | 2015-10-30 | Takeda Pharmaceuticals Co | Związki dihydropirolonaftyrydynony jako inhibitory JAK |
| RU2498986C2 (ru) * | 2011-07-20 | 2013-11-20 | Учреждение Российской Академии Наук Институт Проблем Химической Физики Ран (Ипхф Ран) | ТЕТРАЦИАНОЗАМЕЩЕННЫЕ 1,4,9b-ТРИАЗАФЕНАЛЕНЫ И СПОСОБ ИХ ПОЛУЧЕНИЯ |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6403599B1 (en) | 1995-11-08 | 2002-06-11 | Pfizer Inc | Corticotropin releasing factor antagonists |
| ZA973884B (en) | 1996-05-23 | 1998-11-06 | Du Pont Merck Pharma | Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders |
| JP2002529465A (ja) * | 1998-11-12 | 2002-09-10 | ニューロクライン バイオサイエンシーズ， インコーポレイテッド | Ｃｒｆレセプターアンタゴニストおよびｃｒｆレセプターアンタゴニストに関する方法 |
| CA2349904A1 (en) | 1998-11-12 | 2000-05-18 | Neurocrine Biosciences, Inc. | Crf receptor antagonists and methods relating thereto |
| GB0117395D0 (en) | 2001-07-17 | 2001-09-05 | Glaxo Group Ltd | Chemical compounds |
-
2002
- 2002-04-30 EP EP02718405A patent/EP1383498B1/en not_active Expired - Lifetime
- 2002-04-30 AU AU2002249474A patent/AU2002249474B2/en not_active Ceased
- 2002-04-30 KR KR10-2003-7014159A patent/KR20040015205A/ko not_active Withdrawn
- 2002-04-30 MX MXPA03009930A patent/MXPA03009930A/es active IP Right Grant
- 2002-04-30 WO PCT/GB2002/001981 patent/WO2002087573A1/en not_active Ceased
- 2002-04-30 CZ CZ20032945A patent/CZ20032945A3/cs unknown
- 2002-04-30 CN CNA028107454A patent/CN1512883A/zh active Pending
- 2002-04-30 CA CA002446497A patent/CA2446497A1/en not_active Abandoned
- 2002-04-30 ES ES02718405T patent/ES2255610T3/es not_active Expired - Lifetime
- 2002-04-30 DE DE60209885T patent/DE60209885T2/de not_active Expired - Fee Related
- 2002-04-30 BR BR0209035-0A patent/BR0209035A/pt not_active IP Right Cessation
- 2002-04-30 AT AT02718405T patent/ATE320254T1/de not_active IP Right Cessation
- 2002-04-30 PL PL02366854A patent/PL366854A1/xx not_active Application Discontinuation
- 2002-04-30 TW TW091108900A patent/TWI236908B/zh not_active IP Right Cessation
- 2002-04-30 HU HU0304035A patent/HUP0304035A2/hu unknown
- 2002-04-30 AR ARP020101598A patent/AR033296A1/es unknown
- 2002-04-30 JP JP2002584918A patent/JP2004528342A/ja active Pending
- 2002-04-30 US US10/476,441 patent/US7329667B2/en not_active Expired - Fee Related
- 2002-04-30 IL IL15806302A patent/IL158063A0/xx unknown
- 2002-04-30 NZ NZ528364A patent/NZ528364A/en unknown
-
2003
- 2003-10-29 NO NO20034837A patent/NO20034837L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US7329667B2 (en) | 2008-02-12 |
| CN1512883A (zh) | 2004-07-14 |
| ATE320254T1 (de) | 2006-04-15 |
| TWI236908B (en) | 2005-08-01 |
| EP1383498B1 (en) | 2006-03-15 |
| WO2002087573A1 (en) | 2002-11-07 |
| US20040235871A1 (en) | 2004-11-25 |
| KR20040015205A (ko) | 2004-02-18 |
| ES2255610T3 (es) | 2006-07-01 |
| JP2004528342A (ja) | 2004-09-16 |
| IL158063A0 (en) | 2004-03-28 |
| BR0209035A (pt) | 2004-08-10 |
| CA2446497A1 (en) | 2002-11-07 |
| NO20034837D0 (no) | 2003-10-29 |
| DE60209885T2 (de) | 2006-08-10 |
| NO20034837L (no) | 2003-12-09 |
| EP1383498A1 (en) | 2004-01-28 |
| DE60209885D1 (de) | 2006-05-11 |
| HUP0304035A2 (hu) | 2004-04-28 |
| CZ20032945A3 (cs) | 2004-02-18 |
| MXPA03009930A (es) | 2004-01-29 |
| PL366854A1 (en) | 2005-02-07 |
| AU2002249474B2 (en) | 2006-01-12 |
| NZ528364A (en) | 2005-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR033295A1 (es) | Compuestos biciclicos de pirimidina, proceso para su obtencion, uso de los mismos para la preparacion de una composicion farmaceutica y dicha composicion farmaceutica | |
| EA200970493A1 (ru) | Макроциклические ингибиторы вируса гепатита с | |
| AR044005A1 (es) | Compuestos biciclicos, procedimiento para su preparacion, su uso para preparar un medicamento y composiciones farmaceuticas que los comprenden | |
| PE20130012A1 (es) | Derivados de pirazol como inhibidores de jak | |
| AR042668A1 (es) | Derivados de fosfonoxi quinazolinas y su uso farmaceutico | |
| AR041566A1 (es) | Derivados de indol utiles para el tratamiento de enfermedades | |
| CO5700754A2 (es) | Derivados de piperazina y su uso en el tratamiento de enfermedades neurologicas y psiquiatricas | |
| BRPI0414084A (pt) | composto, mistura, e, composição | |
| AR043508A1 (es) | 1-amino 1-h-imidazoquinolinas y su uso como inmunomoduladores | |
| AR032130A1 (es) | Un compuesto inhibidor de quinasas proteicas, una composicion farmaceutica que lo incluye, y un metodo para tratar afecciones con dicho compuesto | |
| PE20060570A1 (es) | Compuestos de quinazolina e isoquinolina piperidilo sustituidos como inhibidores de fosfodiesterasa pde-10 | |
| CY1109808T1 (el) | Αρυλινδενο-πυριδινες και αρυλινδενο-πυριμιδινες και η χρηση τους ως ανταγωνιστων των υποδοχεων αδενοσινης α2α | |
| ECSP045073A (es) | Nuevos derivados de piperazina | |
| ECSP099394A (es) | Derivados de quinuclidinol como antogonistas de receptores muscarínicos | |
| UY31750A (es) | Compuestos y composiciones como inhibidores de quinasa | |
| AR041297A1 (es) | Derivados de 4-pirrolidino- fenil- bencil eter | |
| DE602004005960D1 (de) | Heteroaryl-substituierte pyrrolä2, 3- büpyridin-derivate als crf-rezeptor-antagonisten | |
| CR20220116A (es) | Compuestos heterocíclicos | |
| ECSP088257A (es) | Derivados de amida | |
| DE60214401D1 (de) | Hetero-bicyclische crf antagonisten | |
| AR045447A1 (es) | Compuestos triciclicos inhibidores de transferasa de proteina de farnesilo novedosos como agentes antitumorales | |
| UY30673A1 (es) | Derivados 6, 7 y 8 sustituidos del acido (3r)-5-oxo-2,3-dihidro-5h-tiazolo[3,2a]piridin-3-carboxilico, composiciones farmacéuticas conteniéndolos y aplicaciones. | |
| HN2005000370A (es) | Derivados de pirido-pirimidina, su preparacion y su aplicacion en terapeutica | |
| RU2008143546A (ru) | Тиазолилдигидрохиназолины | |
| AR064887A1 (es) | Derivados de piridopirimidina utiles como agentes terapeuticos en trastornos inflamatorios e inmunes, proceso de preparacion de los mismos y composiciones farmaceuticas que lo contienen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |